Rhabdomyolysis induced by nelarabine

Ann Hematol. 2022 Sep;101(9):2111-2112. doi: 10.1007/s00277-022-04879-8. Epub 2022 Jun 17.

Authors

Christian Späth¹, Mandy Schönau¹, Sophie Gaubert¹, Thomas Neumann¹, Christian A Schmidt¹, Florian H Heidel¹, William H Krüger²

Affiliations

¹ Clinic for Internal Medicine C - Haematology and Oncology, Stem Cell Transplantation and Palliative Care, University Medicine Greifswald, Ferdinand-Sauerbruch-Straße, 17475, Greifswald, Germany.
² Clinic for Internal Medicine C - Haematology and Oncology, Stem Cell Transplantation and Palliative Care, University Medicine Greifswald, Ferdinand-Sauerbruch-Straße, 17475, Greifswald, Germany. william.krueger@med.uni-greifswald.de.

No abstract available

Publication types

Letter

MeSH terms

Arabinonucleosides / adverse effects
Humans
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*
Rhabdomyolysis* / chemically induced

Substances

Arabinonucleosides
nelarabine